Latest Insider Transactions at Drugs Made In America Acquisition Ii Corp. (DMII)
This section provides a real-time view of insider transactions for Drugs Made In America Acquisition Ii Corp. (DMII). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Drugs Made In America Acquisition II Corp. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Drugs Made In America Acquisition II Corp.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 26
2025
|
Catherine Do Director |
BUY
Other acquisition or disposition
|
Direct |
100,000
+50.0%
|
-
|
|
Sep 26
2025
|
Myron W. Shulgan Director |
BUY
Other acquisition or disposition
|
Direct |
100,000
+50.0%
|
-
|
|
Sep 26
2025
|
Glenn C. Worman CFO |
BUY
Other acquisition or disposition
|
Direct |
100,000
+50.0%
|
-
|
|
Sep 26
2025
|
Lynn Stockwell CEO and Exe. Chair of Board |
SELL
Open market or private sale
|
Indirect |
7,966,667
-54.29%
|
-
|
|
Sep 26
2025
|
Lynn Stockwell CEO and Exe. Chair of Board |
SELL
Other acquisition or disposition
|
Indirect |
400,000
-2.65%
|
-
|
|
Sep 26
2025
|
Lynn Stockwell CEO and Exe. Chair of Board |
BUY
Open market or private purchase
|
Indirect |
700,000
+4.44%
|
-
|
|
Sep 26
2025
|
Drugs Made In America Acquisition Ii LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,966,667
-54.29%
|
-
|
|
Sep 26
2025
|
Drugs Made In America Acquisition Ii LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
400,000
-2.65%
|
-
|
|
Sep 26
2025
|
Drugs Made In America Acquisition Ii LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
700,000
+4.44%
|
-
|
|
Sep 26
2025
|
Sridhar G. Prasad Director |
BUY
Other acquisition or disposition
|
Direct |
100,000
+50.0%
|
-
|